pentobarbital will lower the level or influence of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Keep an eye on clients presently on buprenorphine subdermal implant who involve freshly-initiated therapy with CYP3A4 inducer for signs and symptoms of withdrawal.Parenteral d